Nextage Therapeutics Ltd (NXTG.TA)

ILA 72.8

(-3.45%)

Operating Expenses Summary of Nextage Therapeutics Ltd

  • Nextage Therapeutics Ltd's latest annual operating expenses in 2023 was 4.21 Million ILS , down -27.94% from previous year.
  • Nextage Therapeutics Ltd's latest quarterly operating expenses in 2023 FY was 4.21 Million ILS , down -27.94% from previous quarter.
  • Nextage Therapeutics Ltd reported a annual operating expenses of 5.84 Million ILS in annual operating expenses 2022, down -9.63% from previous year.
  • Nextage Therapeutics Ltd reported a annual operating expenses of 6.46 Million ILS in annual operating expenses 2021, up 25.4% from previous year.
  • Nextage Therapeutics Ltd reported a quarterly operating expenses of 2.3 Million ILA for 2023 Q2, down -19.26% from previous quarter.
  • Nextage Therapeutics Ltd reported a quarterly operating expenses of 1.91 Million ILA for 2023 Q4, down -17.03% from previous quarter.

Annual Operating Expenses Chart of Nextage Therapeutics Ltd (2023 - 2016)

Historical Annual Operating Expenses of Nextage Therapeutics Ltd (2023 - 2016)

Year Operating Expenses Operating Expenses Growth
2023 4.21 Million ILS -27.94%
2022 5.84 Million ILS -9.63%
2021 6.46 Million ILS 25.4%
2020 5.15 Million ILS 151.49%
2019 2.05 Million ILS -78.72%
2018 9.63 Million ILS 55.52%
2017 6.19 Million ILS -13.55%
2016 7.16 Million ILS 0.0%

Peer Operating Expenses Comparison of Nextage Therapeutics Ltd

Name Operating Expenses Operating Expenses Difference
Cannabotech LTD 15.36 Million ILA 72.592%